Position in ARVN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$493,040
-$135,868 QoQ
Shares Held
59,331
0.0% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#79
of 198 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GLOBEFLEX CAPITAL L P holds $30,619,322 across 13 Biotechnology names. ARVN ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
254,993 | $13,874,169 | |
| 2 | RIGL |
Rigel Pharmaceuticals Inc
|
112,672 | $4,407,728 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
382,807 | $3,104,564 | |
| 4 | ZVRA |
Zevra Therapeutics, Inc.
|
191,904 | $2,751,903 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
10,645 | $2,565,125 | |
| 6 | AGEN |
Agenus Inc
|
418,581 | $1,280,857 | |
| 7 | INCY |
Incyte Corp
|
8,654 | $981,017 | |
| 8 | ARVN |
Arvinas, Inc.
This page
|
59,331 | $493,040 |
All Filings in ARVN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $493,040 | 59,331 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $628,908 | 59,331 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $131,978 | 11,128 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||